Shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Get Free Report) shot up 65.3% during mid-day trading on Tuesday . The company traded as high as $17.29 and last traded at $17.29. 8,004 shares were traded during trading, a decline of 55% from the average session volume of 17,917 shares. The stock had previously closed at $10.46.
Translational Development Acquisition Stock Performance
The stock’s 50-day moving average price is $10.75 and its 200-day moving average price is $10.55.
Translational Development Acquisition Company Profile
Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.
In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.
Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
